11 studies were found.

1.		Completed	BAY 43-9006 in Patients with Advanced Hepatocellular Carcinoma Condition: Carcinoma, Hepatocellular
2.		Completed	Discontinuation Study of BAY 43-9006 in Patients with Advanced Refractory Cancer Conditions: Colorectal Neoplasm; Carcinoma, Renal Cell
3.		Terminated	Evaluation of Bay 59-8862 in Patients with Advanced Renal Cell Carcinoma Condition: Carcinoma, Renal Cell
4.		Terminated	Evaluation of Bay 59-8862 in Patients with Aggressive, Refractory Non-Hodgkin's Lymphoma Condition: Lymphoma, Non-Hodgkin
5.		Terminated	Evaluation of Bay 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients Condition: Carcinoma, Non-Small-Cell Lung
6.		Terminated	Evaluation of Bay 59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients Conditions: Breast Neoplasms; Metastases, Neoplasm
7.		Recruiting	Repinotan in Patients with Acute Ischemic Stroke Condition: Acute ischemic stroke
8.		Recruiting	Safety and efficacy of BAY 50-4798 in patients with HIV infection Condition: HIV Infections
9.		Recruiting	Study of BAY 43-9006 in Patients with Unresectable and/or Metastatic Renal Cell Cancer Condition: Carcinoma, Renal Cell
10.		Completed	A Study to Estimate Safety and Efficacy of Bay 43-9006 in the Treatment of Hepatocellular Carcinoma Condition: Carcinoma, Hepatocellular
11.		Completed	A Two Stage Study of the Safety and Efficacy of Bay 43-9006 in Colorectal Cancer and Other Cancers Conditions: Colorectal Cancer; Tumors